99Tc-MDP for Thyroid-Associated Ophthalmopathy
NCT03948191
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Thyroid-Associated Ophthalmopathy
Interventions
DRUG:
Methylprednisolone
DRUG:
99Tc-MDP(99Technetium-Methylenediphosphonate Injection)
Sponsor
Dalian University